Immunic Inc (IMUX)
1.37
+0.04
(+3.01%)
USD |
NASDAQ |
May 03, 16:00
1.38
+0.01
(+0.73%)
After-Hours: 20:00
Immunic Max Drawdown (5Y): 99.70% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.70% |
March 31, 2024 | 99.70% |
February 29, 2024 | 99.70% |
January 31, 2024 | 99.70% |
December 31, 2023 | 99.70% |
November 30, 2023 | 99.70% |
October 31, 2023 | 99.70% |
September 30, 2023 | 99.70% |
August 31, 2023 | 99.70% |
July 31, 2023 | 99.70% |
June 30, 2023 | 99.70% |
May 31, 2023 | 99.70% |
April 30, 2023 | 99.70% |
March 31, 2023 | 99.70% |
February 28, 2023 | 99.70% |
January 31, 2023 | 99.70% |
December 31, 2022 | 99.70% |
November 30, 2022 | 99.65% |
October 31, 2022 | 99.60% |
September 30, 2022 | 99.60% |
August 31, 2022 | 99.60% |
July 31, 2022 | 99.60% |
June 30, 2022 | 99.60% |
May 31, 2022 | 99.60% |
April 30, 2022 | 99.60% |
Date | Value |
---|---|
March 31, 2022 | 99.60% |
February 28, 2022 | 99.60% |
January 31, 2022 | 99.60% |
December 31, 2021 | 99.60% |
November 30, 2021 | 99.60% |
October 31, 2021 | 99.60% |
September 30, 2021 | 99.60% |
August 31, 2021 | 99.60% |
July 31, 2021 | 99.60% |
June 30, 2021 | 99.60% |
May 31, 2021 | 99.60% |
April 30, 2021 | 99.60% |
March 31, 2021 | 99.60% |
February 28, 2021 | 99.60% |
January 31, 2021 | 99.60% |
December 31, 2020 | 99.60% |
November 30, 2020 | 99.60% |
October 31, 2020 | 99.60% |
September 30, 2020 | 99.60% |
August 31, 2020 | 99.60% |
July 31, 2020 | 99.60% |
June 30, 2020 | 99.60% |
May 31, 2020 | 99.60% |
April 30, 2020 | 99.60% |
March 31, 2020 | 99.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.49%
Minimum
May 2019
99.70%
Maximum
Dec 2022
99.61%
Average
99.60%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Kymera Therapeutics Inc | -- |
Insmed Inc | 63.30% |
SELLAS Life Sciences Group Inc | 100.00% |
Skye Bioscience Inc | 99.47% |
Leap Therapeutics Inc | 97.02% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -61.63 |
Beta (5Y) | 1.926 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.00% |
Historical Sharpe Ratio (5Y) | -0.414 |
Historical Sortino (5Y) | -0.8164 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.67% |